Ovid Therapeutics Inc. (OVID) › Shares OutstandingOvid Therapeutics Inc. (OVID) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2016: 9.84M2017: 24.61M2018: 24.65M2019: 54.71M2020: 65.74M2021: 70.36M2022: 70.47M2023: 70.69M2024: 71.01M2025: 130.18M130.18M2016Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025130.18M+83.3%202471.01M+0.4%202370.69M+0.3%202270.47M+0.1%202170.36M+7.0%202065.74M+20.2%201954.71M+121.9%201824.65M+0.2%201724.61M+150.1%20169.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share